Skip to main content

Table 4 Comparison of PHQ-9 and GAD-7 scores within the epilepsy group

From: Anxiety and depression among epilepsy patients in low-risk areas for COVID-19 in the northern part of Guizhou Province, China, during the COVID-19 pandemic

  Epilepsy patients
n = 200
PHQ-9 Z/χ2 P GAD-7 Z/χ2 P
n % Median (P25, P75)    Median (P25, P75)   
Sex     −3.263 0.001   −2.535 0.011
 Male 89 44.50 1 (0, 5)    0 (0,4)   
 Female 111 55.50 4 (0, 10)    3 (0,8)   
Age, years     4.408 0.354   6.451 0.168
 14–23 67 33.50 4 (0, 11)    2 (0,9)   
 24–33 77 38.50 2 (0, 7)    1 (0, 5)   
 34–43 28 14.00 3 (0.25, 10)    3.5 (0, 8.5)   
 44–53 22 11.00 0 (0, 6.5)    0 (0, 4.25)   
  ≥ 54 6 3.00 3.5 (0.75, 9.75)    3 (0, 8)   
Do you pay attention to the COVID-19’s epidemic situation every day?     −3.102 0.002   −2.287 0.022
 Yes 182 91.00 2 (0, 8)    1 (0, 6)   
 No 18 8.00 7.5 (4, 10.5)    4.5 (1.75, 9.5)   
Is life disrupted?     −1.21 0.226   −1.423 0.155
 Yes 118 59.00 4 (0, 8)    3 (0, 5)   
 No 82 41.00 1 (0, 8.25)    1 (0, 5)   
Type of medication     −0.098 0.922   −1.556 0.12
A single ASM 130 65.00 2 (0, 8)    2 (0, 5)   
A combination of ASMs 70 35.00 2.5 (0, 10.25)    2.5 (0, 7.25)   
Did you have seizures in the past month?     −0.91 0.363   −1.08 0.28
 Yes 74 37.00 3 (0, 9.25)    3 (0, 7)   
 No 126 63.00 2 (0, 7.25)    1 (0, 5.25)   
  1. GAD-7 Generalized Anxiety Disorder-7, PHQ-9 Patient Health Questionnaire 9, ASM Anti-seizure medicine